Literature DB >> 9367021

Correlation of lipid content and composition with liposarcoma histology and grade.

S Singer1, K Millis, K Souza, C Fletcher.   

Abstract

BACKGROUND: The determination of sarcoma grade, histologic type, and differentiation is often pathologist dependent and requires considerable expertise.
METHODS: Lipid content and composition was analyzed in ex vivo fat, lipoma, and liposarcoma tissue samples using proton-decoupled 13C nuclear magnetic resonance (13C-NMR) spectroscopy and correlated with the histologic type and grade of liposarcoma.
RESULTS: The well-differentiated liposarcomas were found to have threefold increases in fatty acyl chain content compared with benign lipomas. The fatty acyl chain content of the dedifferentiated and pleomorphic liposarcomas was 1% of that found in lipoma and < 0.2% of that found in well-differentiated liposarcoma. The 2.1- to 2.8-fold increase in the degree of polyunsaturation in the dedifferentiated and pleomorphic liposarcomas compared with well-differentiated liposarcoma could largely be accounted for by the 2.3-fold increase in the percentage of fatty acyl chains of lipid containing linoleic acid. The dedifferentiated and pleomorphic liposarcomas contained both free fatty acids and phospholipids that were not NMR detectable in normal fat, lipoma, and well-differentiated liposarcoma.
CONCLUSION: Ex vivo 13C-NMR spectroscopy may be used to distinguish lipoma from well-differentiated, dedifferentiated, and pleomorphic liposarcoma based on changes in lipid and phospholipid metabolite profiles and may serve as adjunct to conventional light microscopy for the determination of liposarcoma histologic type and thus grade.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9367021     DOI: 10.1007/bf02305536

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  9 in total

Review 1.  Metabolomics in the fields of oncology: a review of recent research.

Authors:  Yanlei Ma; Peng Zhang; Yongzhi Yang; Feng Wang; Huanlong Qin
Journal:  Mol Biol Rep       Date:  2012-02-16       Impact factor: 2.316

2.  Intraoperative Raman spectroscopy of soft tissue sarcomas.

Authors:  John Q Nguyen; Zain S Gowani; Maggie O'Connor; Isaac J Pence; The-Quyen Nguyen; Ginger E Holt; Herbert S Schwartz; Jennifer L Halpern; Anita Mahadevan-Jansen
Journal:  Lasers Surg Med       Date:  2016-07-25       Impact factor: 4.025

3.  Inhibition of polo like kinase 1 in sarcomas induces apoptosis that is dependent on Mcl-1 suppression.

Authors:  Jayasree S Nair; Gary K Schwartz
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

4.  A developmental model of sarcomagenesis defines a differentiation-based classification for liposarcomas.

Authors:  Igor Matushansky; Eva Hernando; Nicholas D Socci; Tulio Matos; Joslyn Mills; Mark A Edgar; Gary K Schwartz; Samuel Singer; Carlos Cordon-Cardo; Robert G Maki
Journal:  Am J Pathol       Date:  2008-02-29       Impact factor: 4.307

5.  Tissue and serum lipidome shows altered lipid composition with diagnostic potential in mycosis fungoides.

Authors:  Chenchen Xu; Dan Zhou; Yixin Luo; Shuai Guo; Tao Wang; Jie Liu; Yuehua Liu; Zhili Li
Journal:  Oncotarget       Date:  2017-07-18

6.  Characterization of lipomatous tumors with high-resolution 1H MRS at 17.6T: Do benign lipomas, atypical lipomatous tumors and liposarcomas have a distinct metabolic signature?

Authors:  Santosh Kumar Bharti; Brett A Shannon; Raj Kumar Sharma; Adam S Levin; Carol D Morris; Zaver M Bhujwalla; Laura M Fayad
Journal:  Front Oncol       Date:  2022-09-09       Impact factor: 5.738

Review 7.  On the Relevance of Soft Tissue Sarcomas Metabolic Landscape Mapping.

Authors:  Miguel Esperança-Martins; Iola F Duarte; Mara Rodrigues; Joaquim Soares do Brito; Dolores López-Presa; Luís Costa; Isabel Fernandes; Sérgio Dias
Journal:  Int J Mol Sci       Date:  2022-09-28       Impact factor: 6.208

8.  Statistical classification strategy for proton magnetic resonance spectra of soft tissue sarcoma: an exploratory study with potential clinical utility.

Authors:  Tedros Bezabeh; Samy El-Sayed; Rakesh Patel; Ray L Somorjai; Vivien Bramwell; Rita Kandel; Ian C P Smith
Journal:  Sarcoma       Date:  2002

9.  MLN-8237: A dual inhibitor of aurora A and B in soft tissue sarcomas.

Authors:  Jayasree S Nair; Gary K Schwartz
Journal:  Oncotarget       Date:  2016-03-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.